February 27, 2023

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

OTHER PROTOCOL NOTICES

1. ALL DISEASE SITES

NRG-GY022: Reminder: Actively Recruiting MALE Patients only Read More

2. CANCER PREVENTION & CONTROL

NRG-CC005/FORTE: The NRG FORTE team has created several documents related to the social media presence for FORTE during Colorectal Cancer Awareness Month (March). The “Colorectal Cancer Awareness Month” document is patient-facing and CIRB-approved, while the memorandum, dated February 22, 2023, and guide are educational materials for research staff. All of these materials are posted on CTSU.

3. GYNECOLOGIC

Printing Biospecimen Transmittal PDFs on GYN Trials

Please note an effort is underway to clarify how to obtain a Biospecimen Transmittal PDF for submission to the NRG Oncology Biospecimen Bank. Read More

GOG-0210: Reminder: Biospecimens, biomarker data, clinical data, and epidemiologic data are available for request. Please visit the NRG Oncology website for more information on this important study with the overall goal of improving the outcome and/or quality of life for patients with endometrial cancer.

NRG-GY012 and NRG-GY023 – Reminder: BLOOD PRESSURE CUFF SUPPLY IS VERY LIMITED - Please be advised that VWR has a very limited supply of blood pressure cuffs at present. Please check your supplies on site for any overlooked cuffs prior to ordering. Thank you for your cooperation. 

4. HEAD & NECK

NRG-HN008

Reminder: please update treatment and AE data weekly. This is a Phase I trial and timely data submission is very important. 

5. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, NRG-CC005, and NRG/SWOG S1914. Space is limited so register now and reserve your seat. The next webinar training is scheduled for Wednesday, March 8, 2023.

Expansion of Safety-Lead in Sites for NRG Phase I Committee

The NRG Phase I Subcommittee is looking to expand the number of sites who can participate on the safety lead-in component of studies. Key considerations for being a safety lead-in site are:

• the ability to enter patient safety data in real-time
• site physician member or physician delegate must participate on safety calls (currently Friday afternoons at 3:30PM ET). Click here for application and more information.

Responses requested by March 20, 2023.

Call for Applications for 2 NRG Committee Leadership Positions

Vice Chair, NRG Immunotherapy Subcommittee

Application Deadline: March 15, 2023

We are seeking nominations for the position of Vice-Chair, NRG Immunotherapy Subcommittee. This subcommittee within NRG sits within the NRG Medical Oncology Committee, a Scientific Core Committee, and aides in cross-group collaboration and engagement around immune-therapy agents and serving as subject matter experts on related topics. Subcommittee members will help liaise within the disease-specific committees in supporting developing concepts and protocols where immune-oncology agents may be appropriate for the patient cohorts in NRG’s portfolio. Click here for more information.

Chair, NRG Publications Committee

Application Deadline: March 15, 2023

We are seeking nominations for the position of Chair, NRG Oncology Publications Committee. The Publication Committee within NRG promotes and facilitates the publication of studies to ensure NRG Oncology results are published in a timely manner, assures authorship lines are appropriate, reviews the science of abstracts and papers, assures timely reporting by assigning or reassigning responsibility, monitoring compliance with the Publication Policy, and proposes recommendations to update the Publications Policy as necessary. The Publications Committee may be required to consider and adjudicate appeals and/or disputes related to publications and may be required to issue recommendations to the Group Chairs for final decision. Click here for more information.

Survey: Neurotization at Time of NSM

We would like site feedback regarding the feasibility of developing a protocol: A phase II Randomized Control Trial of Neurotization of the Nipple Areolar Complex at the time of Nipple Sparing Mastectomy and Prosthetic Based Reconstruction. Neurotization is a surgical technique using a nerve graft to reinnervate the nipple areola complex and restore sensation at the time of nipple sparing mastectomy. There is a large gap in understanding the effectiveness of the procedure and an unmet need exists in determining how the procedure is associated with quality of life. We hypothesize nerve grafting of the nipple areolar complex at the time of nipple sparing mastectomy will restore sensation and improve patient-reported outcomes. Thank you for your time and attention in completing our survey.

Click here to complete the survey: https://www.surveymonkey.com/r/5W76ZTF

NRG Oncology Study Overview Videos for Investigators

The NRG Oncology Communications Team has been conducting video interviews with study PIs for NRG trials that are currently open to accrual. The video interview filmed with Dr. William Hall for NRG-GU012, the SAMURAI Study, at the Winter 2023 NRG Oncology Meeting in Orlando is now posted on the NRG Oncology YouTube channel and also linked on the NRG Protocol table under “Documents and Materials” for the corresponding study.

NRG Mentorship Working Group Update

Are you a new CRA or CTN within NRG Oncology? Would you like a mentor to help guide you through your new role as a CRA or CTN? Are you an institution in need of more guidance after an audit? The Mentorship Working Group can provide you a mentor! You can apply for a mentor by going to the Introductory Materials page on the NRG website. You will find the Mentor Form to complete. The instructions on how to submit are located on the form. Hope to hear from you soon!

Request for NCORP PILOT Project Applications

Date Issued: February 17, 2023

Submission Due Date: April 21, 2023

NRG Oncology NCORP solicits PILOT projects addressing NRG NCORP Cancer Care Delivery Research (CCDR), Cancer Prevention and Control (CPC) Research and Health Disparities Research (HDR) priorities. PILOT projects should generate preliminary data and address feasibility issues to inform the development of a future NCORP concept. Refer to the links below for further details.

Cancer Care Delivery Research (CCDR)

Cancer Prevention and Control (CPC)

Health Disparities Research (HDR)

PUBLICATIONS REMINDERS

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

JOURNAL ARTICLES

Tsien CI, Pugh SL, Dicker AP, Raizer JJ, Matuszak MM, Lallana EC, Huang J, Algan O, Deb N, Portelance L, Villano JL, Hamm JT, Oh KS, Ali AN, Kim MM, Lindhorst SM, Mehta MP. NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma. J Clin Oncol. 2023 Feb 20;41(6):1285-1295. doi: 10.1200/JCO.22.00164. Epub 2022 Oct 19. PMID: 36260832; PMCID: PMC9940937. Read more

Please note the following upcoming meeting and abstract submission deadline dates

UPCOMING MEETINGS

American Association for Cancer Research (AACR); Apr 14-19, 2023; Orlando, FL

American Association for Thoracic Surgery (AATS); May 6-9, 2023; Los Angeles, CA

American College of Radiology (ACR); May 6-10, 2023; Washington, DC

Miami Breast Cancer Conference; Mar 2-5, 2023; Miami, FL

Society of Gynecologic Oncology (SGO); Mar 25-28, 2023; Tampa, FL

Society of Surgical Oncology (SSO); Mar 22-25, 2023; Boston, MA

St. Gallen Breast Cancer Conference (SG-BCC); Mar 15-18, 2023; Vienna, Austria



UPCOMING ABSTRACT SUBMISSION DEADLINES

American Association of Physicists in Medicine (AAPM); Jul 23-27, 2023; Houston, TX; meeting submission deadline Feb 28, 2023, 8:00pm ET

American Society of Clinical Oncology (ASCO); Jun 2-6, 2023; Chicago, IL; LBA Mar 16, 2023, 12Noon EST

American Society for Radiation Oncology (ASTRO); Oct 1-4, 2023; Chicago, IL; LBA Jul 23, 2023

ESMO World Congress on Gastrointestinal Cancer; Jun 28-Jul 1, 2023; Barcelona, Spain; due to publications committee Feb 27, 2023; meeting submission deadline Mar 13, 2023; LBA Jun 15, 2023

European Society of Gynaecological Oncology (ESGO); Sep 28-Oct 1, 2023; Istanbul, Turkey; due to publications committee Apr 24, 2023; meeting submission deadline May 8, 2023; LBA Aug 7, 2023

European Society for Medical Oncology (ESMO) Congress; Oct 20-24, 2023; Madrid, Spain; due to publications committee Apr 26, 2023; meeting submission deadline May 10, 2023, 9pm CntEurSummerTime (CEST); LBA Sep 14, 2023, 9:00pm CEST

International Gynecologic Cancer Society (IGCS); Nov 5-7, 2023; Seoul, South Korea; due to publications committee Apr 3, 2023; meeting submission deadline May 8, 2023 Oral, Poster, Surg Film; TPS, LBA Aug 21, 2023

International Society for Quality-of-Life Research (ISOQOL); Oct 18-21, 2023; Calgary, AB Canada; due to publications committee March 20, 2023; LBA Jul 7, 2023

Radiological Society of North America (RSNA); Nov 27-Dec 1, 2023; Chicago, IL; due to publications committee Apr 19, 2023; meeting submission deadline; May 3, 2023 12Noon CT